Prorelix Research01 Feb, 2022Health
The incidence of diabetes and obesity are increasing on a global scale and ProRelix Research is playing a significant role in supporting development of new therapies to treat these types of chronic metabolic disorders. We have deep experience and expertise not only in recruiting specialized patient populations but also in retaining them for longer-term studies. ProRelix?s Endocrinology and Diabetes experience include over many studies in different phases through Registry and with Medical Devices IDE and non-IDE stages.
Haley Lauritzen
Hastings Roche
Erichsen Maclean
Links To Life Early Intervention Pty Ltd
Lindberg Lott
Roberson Mcdaniel
Pittman Mercer
Daly Stephenson
Sandberg Soto
Stack Vazquez